comparemela.com

Latest Breaking News On - Thomas equels - Page 1 : comparemela.com

AIM ImmunoTech Inc. (AMEX:AIM) Q1 2024 Earnings Call Transcript

AIM ImmunoTech Inc. (AMEX:AIM) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Chad
Washington
United-states
Netherlands
North-carolina
Charlotte
Chris-mcaleer
Charles-lapp
Thomas-equels
James-molloy
Jason-mccarthy
Christopher-mcaleer

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

OCALA, Fla., April 25, 2024 AIM ImmunoTech Inc.  , today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Thomas Equels, Chief.

United-states
American
Thomas-equels
Linkedin
Astrazeneca
Facebook
Immunotech-inc
Chief-executive-officer
Metastatic-pancreatic-cancer
Markets

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

AIM ImmunoTech Announces Release of the Next CEO Corner Segment
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Thomas-equels
Linkedin
Facebook
Immunotech-inc
Chief-executive-officer
Locally-advanced-pancreatic-adenocarcinoma

AIM ImmunoTech Announces Release of the Next CEO Corner Segment

OCALA, Fla., April 11, 2024 AIM ImmunoTech Inc.  , today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Thomas Equels, Chief.

United-states
American
Thomas-equels
Linkedin
Facebook
Immunotech-inc
Chief-executive-officer
Markets

Aim ImmunoTech Announces Positive Data From Ampligen Study In Combination With Pembrolizumab

(RTTNews) - Aim ImmunoTech Inc. (AIM) announced positive preliminary findings on Wednesday, showing that pairing Ampligen or rintatolimod with Key.

Thomas-equels
Immunotech-inc
Objective-response-rate

vimarsana © 2020. All Rights Reserved.